Multimodality approaches for the curative treatment of esophageal cancer.
about
MTHFR C677T Polymorphism is Associated with Tumor Response to Preoperative Chemoradiotherapy: A Result Based on Previous ReportsUnderstanding Complete Pathologic Response in Oesophageal Cancer: Implications for Management and SurvivalCMISG1701: a multicenter prospective randomized phase III clinical trial comparing neoadjuvant chemoradiotherapy to neoadjuvant chemotherapy followed by minimally invasive esophagectomy in patients with locally advanced resectable esophageal squamouComprehensive Genomic Profiling of Advanced Esophageal Squamous Cell Carcinomas and Esophageal Adenocarcinomas Reveals Similarities and Differences.Current treatment options for esophageal diseases.Survival benefit of surgery to patients with esophageal squamous cell carcinomaHybrid minimally invasive Ivor Lewis esophagectomy after neoadjuvant chemoradiation yields excellent long-term survival outcomes with minimal morbidity.Post-operative radiotherapy is associated with improved survival in esophageal cancer with positive surgical margins.Effect of consolidation chemotherapy following definitive chemoradiotherapy in patients with esophageal squamous cell cancer.Cervical ultrasonography has no additional value over negative 18F-FDG PET/CT scans for diagnosing cervical lymph node metastases in patients with oesophageal cancer.Upfront surgery and pathological stage-based adjuvant chemoradiation strategy in locally advanced esophageal squamous cell carcinoma.Accuracy of preoperative staging for a priori resectable esophageal cancer.Cutaneous Angiosarcoma: The Possibility of New Treatment Options Especially for Patients with Large Primary Tumor.Downregulation of HOXA13 sensitizes human esophageal squamous cell carcinoma to chemotherapy.
P2860
Q26784493-0C176CA9-87F7-4D9C-BB8B-291F67DD830CQ26798220-6FA9D045-86A9-4F6B-B60F-FF4038EF86BFQ33850915-3420BC4A-10FA-4727-9C1B-9058114FC3B5Q35763725-3D632882-7E95-44D6-A5FB-29F2CBB92033Q38890205-CEC954EF-288F-4337-BDB7-BF7AF89CFC2BQ39223929-B8C17E23-76F8-4B11-9755-4141509C62E4Q40510182-EF66F3BC-02A7-4857-8F00-D6E7C882C427Q47106223-D70F92F2-6A81-4D17-AA3B-3C04656118FAQ47159390-ACD845FA-A8B8-41BA-9F51-2701DA6533EEQ47346415-0C7636A9-9A8F-47E1-9AD7-FF806B9A1577Q47639150-269215D8-A825-4377-9E0C-7164B7E74DFBQ49964109-5E1CA4B9-8A96-492F-976C-3BA41308F033Q52649466-A5A2C903-FC01-4E23-A04E-69858F0EC8C5Q53682858-2C35D9C8-9288-43BA-AB21-412438E88334
P2860
Multimodality approaches for the curative treatment of esophageal cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Multimodality approaches for the curative treatment of esophageal cancer.
@en
type
label
Multimodality approaches for the curative treatment of esophageal cancer.
@en
prefLabel
Multimodality approaches for the curative treatment of esophageal cancer.
@en
P2093
P356
P1476
Multimodality approaches for the curative treatment of esophageal cancer.
@en
P2093
Gail Darling
Raymond Jang
Rebecca K S Wong
P304
P356
10.6004/JNCCN.2015.0029
P577
2015-02-01T00:00:00Z